Financhill
Buy
57

CGNX Quote, Financials, Valuation and Earnings

Last price:
$31.63
Seasonality move :
3.2%
Day range:
$29.44 - $30.01
52-week range:
$22.67 - $53.13
Dividend yield:
1.05%
P/E ratio:
43.34x
P/S ratio:
5.51x
P/B ratio:
3.42x
Volume:
2.2M
Avg. volume:
3.4M
1-year change:
-36.62%
Market cap:
$4.9B
Revenue:
$914.5M
EPS (TTM):
$0.68

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CGNX
Cognex
$212.3M $0.13 3.25% 12.06% $37.28
FCUV
Focus Universal
-- -- -- -- --
KEYS
Keysight Technologies
$1.3B $1.65 5.44% 128.71% $177.16
MLAB
Mesa Laboratories
$61.9M $2.07 5.09% 287.18% $141.67
QRVO
Qorvo
$850.5M $1.00 -12.53% 14504.43% $82.98
SOTK
Sono-Tek
$5.1M $0.01 7.48% -- $8.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CGNX
Cognex
$29.47 $37.28 $4.9B 43.34x $0.08 1.05% 5.51x
FCUV
Focus Universal
$4.87 -- $34.7M -- $0.00 0% 73.26x
KEYS
Keysight Technologies
$154.12 $177.16 $26.6B 44.16x $0.00 0% 5.37x
MLAB
Mesa Laboratories
$123.84 $141.67 $672.9M -- $0.16 0.52% 2.83x
QRVO
Qorvo
$73.19 $82.98 $6.8B 125.26x $0.00 0% 1.87x
SOTK
Sono-Tek
$3.94 $8.25 $62M 56.23x $0.00 0% 3.08x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CGNX
Cognex
-- 1.587 -- 1.98x
FCUV
Focus Universal
-- -0.393 -- 4.13x
KEYS
Keysight Technologies
25.66% 1.529 5.8% 1.99x
MLAB
Mesa Laboratories
55.77% 0.569 27.31% 0.45x
QRVO
Qorvo
31.35% 0.615 22.91% 1.80x
SOTK
Sono-Tek
-- 0.589 -- 2.26x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CGNX
Cognex
$144.3M $26.1M 7.82% 7.82% 12.08% $38M
FCUV
Focus Universal
-$127.1K -$2M -77.46% -101.87% -1472.35% -$1M
KEYS
Keysight Technologies
$820M $218M 8.93% 12.1% 16.87% $346M
MLAB
Mesa Laboratories
$39.8M $5.8M -59.87% -122.79% 1% $17.6M
QRVO
Qorvo
$366.6M $28.2M 1.06% 1.61% 4.05% $176.2M
SOTK
Sono-Tek
$2.3M $197.6K 6.6% 6.6% 3.81% $1.1M

Cognex vs. Competitors

  • Which has Higher Returns CGNX or FCUV?

    Focus Universal has a net margin of 10.93% compared to Cognex's net margin of -1472.68%. Cognex's return on equity of 7.82% beat Focus Universal's return on equity of -101.87%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    66.81% $0.14 $1.4B
    FCUV
    Focus Universal
    -95.41% -$0.28 $3.2M
  • What do Analysts Say About CGNX or FCUV?

    Cognex has a consensus price target of $37.28, signalling upside risk potential of 26.49%. On the other hand Focus Universal has an analysts' consensus of -- which suggests that it could fall by --. Given that Cognex has higher upside potential than Focus Universal, analysts believe Cognex is more attractive than Focus Universal.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 10 0
    FCUV
    Focus Universal
    0 0 0
  • Is CGNX or FCUV More Risky?

    Cognex has a beta of 1.455, which suggesting that the stock is 45.497% more volatile than S&P 500. In comparison Focus Universal has a beta of 0.261, suggesting its less volatile than the S&P 500 by 73.875%.

  • Which is a Better Dividend Stock CGNX or FCUV?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 1.05%. Focus Universal offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Focus Universal pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or FCUV?

    Cognex quarterly revenues are $216M, which are larger than Focus Universal quarterly revenues of $133.2K. Cognex's net income of $23.6M is higher than Focus Universal's net income of -$2M. Notably, Cognex's price-to-earnings ratio is 43.34x while Focus Universal's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 5.51x versus 73.26x for Focus Universal. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    5.51x 43.34x $216M $23.6M
    FCUV
    Focus Universal
    73.26x -- $133.2K -$2M
  • Which has Higher Returns CGNX or KEYS?

    Keysight Technologies has a net margin of 10.93% compared to Cognex's net margin of 13.02%. Cognex's return on equity of 7.82% beat Keysight Technologies's return on equity of 12.1%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    66.81% $0.14 $1.4B
    KEYS
    Keysight Technologies
    63.17% $0.97 $7B
  • What do Analysts Say About CGNX or KEYS?

    Cognex has a consensus price target of $37.28, signalling upside risk potential of 26.49%. On the other hand Keysight Technologies has an analysts' consensus of $177.16 which suggests that it could grow by 14.95%. Given that Cognex has higher upside potential than Keysight Technologies, analysts believe Cognex is more attractive than Keysight Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 10 0
    KEYS
    Keysight Technologies
    6 0 0
  • Is CGNX or KEYS More Risky?

    Cognex has a beta of 1.455, which suggesting that the stock is 45.497% more volatile than S&P 500. In comparison Keysight Technologies has a beta of 1.104, suggesting its more volatile than the S&P 500 by 10.426%.

  • Which is a Better Dividend Stock CGNX or KEYS?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 1.05%. Keysight Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Keysight Technologies pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or KEYS?

    Cognex quarterly revenues are $216M, which are smaller than Keysight Technologies quarterly revenues of $1.3B. Cognex's net income of $23.6M is lower than Keysight Technologies's net income of $169M. Notably, Cognex's price-to-earnings ratio is 43.34x while Keysight Technologies's PE ratio is 44.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 5.51x versus 5.37x for Keysight Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    5.51x 43.34x $216M $23.6M
    KEYS
    Keysight Technologies
    5.37x 44.16x $1.3B $169M
  • Which has Higher Returns CGNX or MLAB?

    Mesa Laboratories has a net margin of 10.93% compared to Cognex's net margin of -2.67%. Cognex's return on equity of 7.82% beat Mesa Laboratories's return on equity of -122.79%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    66.81% $0.14 $1.4B
    MLAB
    Mesa Laboratories
    63.26% -$0.31 $350.9M
  • What do Analysts Say About CGNX or MLAB?

    Cognex has a consensus price target of $37.28, signalling upside risk potential of 26.49%. On the other hand Mesa Laboratories has an analysts' consensus of $141.67 which suggests that it could grow by 14.4%. Given that Cognex has higher upside potential than Mesa Laboratories, analysts believe Cognex is more attractive than Mesa Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 10 0
    MLAB
    Mesa Laboratories
    2 1 1
  • Is CGNX or MLAB More Risky?

    Cognex has a beta of 1.455, which suggesting that the stock is 45.497% more volatile than S&P 500. In comparison Mesa Laboratories has a beta of 0.966, suggesting its less volatile than the S&P 500 by 3.358%.

  • Which is a Better Dividend Stock CGNX or MLAB?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 1.05%. Mesa Laboratories offers a yield of 0.52% to investors and pays a quarterly dividend of $0.16 per share. Cognex pays 49.29% of its earnings as a dividend. Mesa Laboratories pays out -1.36% of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or MLAB?

    Cognex quarterly revenues are $216M, which are larger than Mesa Laboratories quarterly revenues of $62.8M. Cognex's net income of $23.6M is higher than Mesa Laboratories's net income of -$1.7M. Notably, Cognex's price-to-earnings ratio is 43.34x while Mesa Laboratories's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 5.51x versus 2.83x for Mesa Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    5.51x 43.34x $216M $23.6M
    MLAB
    Mesa Laboratories
    2.83x -- $62.8M -$1.7M
  • Which has Higher Returns CGNX or QRVO?

    Qorvo has a net margin of 10.93% compared to Cognex's net margin of 3.61%. Cognex's return on equity of 7.82% beat Qorvo's return on equity of 1.61%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    66.81% $0.14 $1.4B
    QRVO
    Qorvo
    42.16% $0.33 $4.9B
  • What do Analysts Say About CGNX or QRVO?

    Cognex has a consensus price target of $37.28, signalling upside risk potential of 26.49%. On the other hand Qorvo has an analysts' consensus of $82.98 which suggests that it could grow by 13.37%. Given that Cognex has higher upside potential than Qorvo, analysts believe Cognex is more attractive than Qorvo.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 10 0
    QRVO
    Qorvo
    4 16 1
  • Is CGNX or QRVO More Risky?

    Cognex has a beta of 1.455, which suggesting that the stock is 45.497% more volatile than S&P 500. In comparison Qorvo has a beta of 1.381, suggesting its more volatile than the S&P 500 by 38.058%.

  • Which is a Better Dividend Stock CGNX or QRVO?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 1.05%. Qorvo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Qorvo pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or QRVO?

    Cognex quarterly revenues are $216M, which are smaller than Qorvo quarterly revenues of $869.5M. Cognex's net income of $23.6M is lower than Qorvo's net income of $31.4M. Notably, Cognex's price-to-earnings ratio is 43.34x while Qorvo's PE ratio is 125.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 5.51x versus 1.87x for Qorvo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    5.51x 43.34x $216M $23.6M
    QRVO
    Qorvo
    1.87x 125.26x $869.5M $31.4M
  • Which has Higher Returns CGNX or SOTK?

    Sono-Tek has a net margin of 10.93% compared to Cognex's net margin of 5.28%. Cognex's return on equity of 7.82% beat Sono-Tek's return on equity of 6.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    66.81% $0.14 $1.4B
    SOTK
    Sono-Tek
    45.14% $0.02 $17.4M
  • What do Analysts Say About CGNX or SOTK?

    Cognex has a consensus price target of $37.28, signalling upside risk potential of 26.49%. On the other hand Sono-Tek has an analysts' consensus of $8.25 which suggests that it could grow by 109.59%. Given that Sono-Tek has higher upside potential than Cognex, analysts believe Sono-Tek is more attractive than Cognex.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 10 0
    SOTK
    Sono-Tek
    2 0 0
  • Is CGNX or SOTK More Risky?

    Cognex has a beta of 1.455, which suggesting that the stock is 45.497% more volatile than S&P 500. In comparison Sono-Tek has a beta of -0.016, suggesting its less volatile than the S&P 500 by 101.624%.

  • Which is a Better Dividend Stock CGNX or SOTK?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 1.05%. Sono-Tek offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Sono-Tek pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or SOTK?

    Cognex quarterly revenues are $216M, which are larger than Sono-Tek quarterly revenues of $5.2M. Cognex's net income of $23.6M is higher than Sono-Tek's net income of $274.2K. Notably, Cognex's price-to-earnings ratio is 43.34x while Sono-Tek's PE ratio is 56.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 5.51x versus 3.08x for Sono-Tek. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    5.51x 43.34x $216M $23.6M
    SOTK
    Sono-Tek
    3.08x 56.23x $5.2M $274.2K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Enovix an Underrated Small Cap?
Is Enovix an Underrated Small Cap?

Enovix (NASDAQ:ENVX) is one of several small, innovative companies hoping…

Are We Heading Toward a Recession?
Are We Heading Toward a Recession?

Fears of a recession in 2025 grew at the end…

3 Recession-Proof ETFs to Invest in Now
3 Recession-Proof ETFs to Invest in Now

The U.S. gross domestic product (GDP) contracted 0.3% during the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 12

Regencell Bioscience Holdings [RGC] is up 28.41% over the past day.

Buy
97
NGVC alert for May 12

Natural Grocers by Vitamin Cottage [NGVC] is down 10.23% over the past day.

Sell
38
ONTO alert for May 12

Onto Innovation [ONTO] is up 5.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock